kevindalby

Originally published on   naturalsearcher.com Technology and advances in research proactively push forward to fight against a wide range of complex diseases called cancer. New drugs are being discovered, and innovative therapies are emerging every year, helping millions of cancer patients get back to their everyday healthy lives. However, many people are still pondering the question: will we ever get to the point where all cancers are cured? Kevin Dalby, UT Austin professor at the Department of Oncology in the College of Pharmacy, is an expert in cancer drug discovery and is studying cancer cell signaling mechanisms to develop targeted therapeutics. In the classroom at UT Austin, Kevin Dalby encourages his students to research to understand cancer better to create new treatments. Below, Dr. Dalby explains why it’s hard to say if all cancers will ever be treated successfully. "Due to the vast range of complicated and diverse factors that make up these diseases, finding a universal ...

  Originally published on   einnews.com Kevin Dalby, UT Austin professor comments on how cancer research clinical trials work and why they are so crucial for the future of cancer treatments. AUSTIN, TEXAS, UNITED STATES, April 20, 2021 /EINPresswire.com/ -- Kevin Dalby, UT Austin professor at the College of Pharmacy, knows the ins and outs of how cancer research trials work. He studies the mechanisms of cancer cell signaling to develop targeted therapeutics. Dalby’s efforts were recognized by the Cancer Prevention and Research Institute of Texas (CPRIT) and the National Institutes of Health, granting him nearly $5 million to support his research. Clinical trials are studies with the main focus of research surrounding a specific disease that involves people. These studies use and observe a new treatment approach to diseases such as a type or stage of cancer and compare it to the most effective treatment known at that time. They bring new waves of innovation to the medical world...